Cystic fibrosis in an adolescent being evaluated for primary sclerosing cholangitis

Seminars in Liver Disease

Volumn 26, Issue 1, 2006, Pages 80-84

  Sinha, Jyoti ^a   Morotti, Raffaella A ^a   Norton, Karen I ^a   Gold, David ^b   Shneider, Benjamin L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Good Samaritan Hospital Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 1 ANTITRYPSIN; AMINOTRANSFERASE; CERULOPLASMIN; LEVOTHYROXINE;

ABDOMINAL DISEASE; ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; CASE REPORT; CYSTIC FIBROSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HYPOTHYROIDISM; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

EID: 33644617585     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-933566     Document Type: Article

References (13)

1. Scott-Jupp R, Lama M, Tanner MS. Prevalence of liver disease in cystic fibrosis. Arch Dis Child 1991;66:698-701
2. Lindblad A, Glaumann H, Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology 1999;30:1151-1158
3. Farber S. Pancreatic function and disease in early life. V: Pathologic changes associated with pancreatic insufficiency in early life. Arch Pathol 1944;37:238-245
4. Bodian M. Fibrocystic Disease of the Pancreas. New York: Grune & Stratton; 1953:104-119
5. Colombo C, Battezzati PM, Strazzabosco M, Podda M. Liver and biliary problems in cystic fibrosis. Semin Liver Dis 1998;18:227-235
6. Strandvik B, Hjelte L, Gabrielsson N, Glaumann H. Sclerosing cholangitis in cystic fibrosis. Scand J Gastroenterol 1988;143(suppl):121-124
7. Nagel RA, Westaby D, Javaid A, et al. Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet 1989;2:1422-1425
8. Dodd GD III, Niedzwiecki GA, Campbell WL, Baron RL. Bile duct calculi in patients with primary sclerosing cholangitis. Radiology 1997;203:443-447
9. Girodon E, Sternberg D, Chazouilleres O, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis. J Hepatol 2002;37:192-197
10. Colombo C, Battezzati PM. Liver involvement in cystic fibrosis: primary organ damage or innocent bystander? J Hepatol 2004;41:1041-1044
11. O'Brien S, Keogan M, Casey M, et al. Biliary complications of cystic fibrosis. Gut 1992;33:387-391
12. Feranchak AP, Sokol RJ. Cholangiocyte biology and cystic fibrosis liver disease. Semin Liver Dis 2001;21:471-488
13. Sheth S, Shea JC, Bishop MD, et al. Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis. Hum Genet 2003;113:286-292